Recruiting Spinal Muscular Atrophy Studies in Detroit
About Spinal Muscular Atrophy Clinical Trials in Detroit
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.
There are currently 19 spinal muscular atrophy clinical trials recruiting participants in Detroit, ME. These studies are seeking a combined 5,222 participants. Research is being sponsored by Barbara Ann Karmanos Cancer Institute, Seagen, a wholly owned subsidiary of Pfizer, Revolution Medicines, Inc. and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Spinal Muscular Atrophy Clinical Trials in Detroit — FAQ
Are there spinal muscular atrophy clinical trials in Detroit?
Yes, there are 19 spinal muscular atrophy clinical trials currently recruiting in Detroit, ME. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Detroit?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.
Are clinical trials in Detroit free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.
What spinal muscular atrophy treatments are being tested?
The 19 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.
Data updated July 13, 2026 from ClinicalTrials.gov